Home Innovation That Matters

Innovation That Matters

Platform for Success: Gossamer Bio’s Quest to Build a Sustainable Company & Culture

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) When Celgene bought San Diego-based biotech Receptos for $7.8 billion in 2015, it was bittersweet for Receptos founders Faheem Hasnain and Sheila Gujrathi. They enjoyed working together, along with their other colleagues, and had...

Algomedix Hopes New Class of Pain Drugs Will Curb Dangers of Opioids

While the opioid epidemic in the US has become a serious public health issue, research into alternative, non-addictive pain drug research and development in the US pharmaceutical industry has not matched the urgent need. However, innovative and more nimble biotech companies may ultimately come...

Hydra Biosciences sees TRP Ion Channels as Pathway to Opioid Alternatives

While sky-rocketing death tolls from opioid pain drug addiction in the US have dominated the headlines in recent years, only slim effort has been made to find the alternative, non-habit-forming pain-killers doctors need to treat chronic pain. In fact, only a relative handful of...

The Race is on for Drugs to Treat Aging, But the Outcome is Far from Settled

Targeting aging with therapeutic interventions to slow the inexorable march of biological decline is moving from the fringe of biomedical research to legitimacy, but numerous challenges remain before pharmacies start dispensing prescription medicines for a longer life. For starters, governments do not recognize aging as...

‘Shared’ Pathways to Success: Viela Bio’s Quest to Develop First-in-Class Molecules to Treat High Unmet Medical Needs

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) Viela Bio, a new spin-out from biotech trailblazer MedImmune, expects to bring new hope to patients who suffer from autoimmune and inflammatory diseases via its robust pipeline of unique molecules.  Armed with a recent...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

Cyclica CEO Naheed Kurji Says AI Could Create a New Paradigm...

Toronto-based Cyclica President and CEO Naheed Kurji acknowledges that artificial intelligence (AI) is a transformative technology, but he contends it is not the “silver...